FDA

FDA Approves Lilly’s New Breast Cancer Drug Combination

By stayhealthydiscussion

No Comments on FDA Approves Lilly’s New Breast Cancer Drug Combination

4 Min Read

The U.S. FDA has approved Eli Lilly’s Inluriyo and Verzenio combination for adults with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer.